Relationship of hyperlipidemia to comorbidities and lung function in COPD: results of the COSYCONET cohort

K. Kahnert (Munich, Germany)

Source: International Congress 2017 – COPD: risk factors and prognosis
Session: COPD: risk factors and prognosis
Session type: Oral Presentation
Number: 1787
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Kahnert (Munich, Germany). Relationship of hyperlipidemia to comorbidities and lung function in COPD: results of the COSYCONET cohort. 1787

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardio-vascular co-morbidities and severity of lung function impairment in a COPD cohort
Source: Eur Respir J 2006; 28: Suppl. 50, 160s
Year: 2006

Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016

Relationship between lung function disorders and condition of cardiovascular system in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 422s
Year: 2003

Study of microalbuminuria in COPD patients and its association with cardiac comorbidities
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021

Lung function in the patients with COPD and with the combination COPD and grownup's diabetes
Source: Eur Respir J 2003; 22: Suppl. 45, 538s
Year: 2003

Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the German COSYCONET cohort.
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019



Impact of the nutritional status on pulmonary function in COPD patients
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013


Chronic obstructive lung disease and vitamin D status: Relationship with lung function, inflammatory status and exacerbations
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015


The impact of overweight and obesity on acute exacerbations of COPD - subgroup analysis of the Taiwan obstructive lung disease cohort
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017


Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Source: Eur Respir J 2008; 32: 962-969
Year: 2008



Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007



Predictive factors for exacerbation and re-exacerbation in COPD: Results from the Swiss COPD cohort
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016

Comparison of comorbidities between two different subgroups in combined assessment of COPD
Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease
Year: 2016

Associations between comorbid load and baseline characteristics in COPD patients with comorbidities: Preliminary results
Source: International Congress 2014 – Latest insights in chronic care
Year: 2014


Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014


Effect of ICS on glycaemic control in patients with COPD and comorbid type 2 diabetes: Historical case-matched cohort study
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


Effects of lifetime smoking patterns on nutrition, muscular and lung function in early COPD patients from the PAC-COPD cohort study
Source: Eur Respir J 2007; 30: Suppl. 51, 283s
Year: 2007

Metabolic regulation during the co-existence of COPD and DM type2
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Impact of hyperglycaemia and comorbid diabetes mellitus on short and long-term outcome after COPD exacerbation
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013

Cardiovascular diseases (CVD), arterial hypertension (AH) and diabetes mellitus (DM) in a cohort of 609 COPD patients: Associations with the new GOLD classification 2011
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013